{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:28:06Z","timestamp":1790368086297,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ero.2025.10.003","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T01:50:42Z","timestamp":1762393842000},"page":"361-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["How should we manage patients with interferon-gamma release assay-positive results in rheumatology: assessing the risk and long-term prognosis of tuberculosis"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2714-5966","authenticated-orcid":false,"given":"Shinichi","family":"Nogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-3211","authenticated-orcid":false,"given":"Toshihiro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2025.10.003_bib0001","series-title":"WHO Global Tuberculosis Report 2023","year":"2023"},{"key":"10.1016\/j.ero.2025.10.003_bib0002","series-title":"Annual tuberculosis report 2023","year":"2023"},{"key":"10.1016\/j.ero.2025.10.003_bib0003","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/1756-185X.12998","article-title":"The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study","volume":"20","author":"Kato","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"10.1016\/j.ero.2025.10.003_bib0004","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/ard-2022-223335","article-title":"2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","volume":"82","author":"Fragoulis","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ero.2025.10.003_bib0005","first-page":"21","article-title":"Treatment guidelines for latent tuberculosis infection","volume":"89","year":"2014","journal-title":"Kekkaku"},{"issue":"2","key":"10.1016\/j.ero.2025.10.003_bib0006","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/rheumatology\/key208","article-title":"The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatology,"},{"issue":"2","key":"10.1016\/j.ero.2025.10.003_bib0007","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/23744235.2019.1682187","article-title":"High risk of activation of latent tuberculosis infection in rheumatic disease patients","volume":"52","author":"Long","year":"2020","journal-title":"Infect Dis (Lond)"},{"issue":"12","key":"10.1016\/j.ero.2025.10.003_bib0008","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/rheumatology\/kead315","article-title":"Prevalence of LTBI in patients with autoimmune diseases and accuracy of IGRA in predicting TB relapse","volume":"62","author":"Chandrashekara","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.ero.2025.10.003_bib0009","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00296-021-04929-w","article-title":"Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry","volume":"41","author":"Oulkadi","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ero.2025.10.003_bib0010","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3389\/fimmu.2018.02171","article-title":"Update on neutrophil function in severe inflammation","volume":"9","author":"Mortaz","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.10.003_bib0011","first-page":"2416","article-title":"CD64 on neutrophils is a sensitive and specific marker for detection of infection in patients with rheumatoid arthritis","volume":"33","author":"Matsui","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ero.2025.10.003_bib0012","article-title":"Clinical utility of neutrophil CD64 to detect extrapulmonary tuberculosis in three patients with rheumatoid arthritis undergoing treatment with biologics","author":"Nogi","year":"2018","journal-title":"Case Rep Rheumatol"},{"issue":"3","key":"10.1016\/j.ero.2025.10.003_bib0013","first-page":"365","article-title":"Estimation of positive rates of interferon-gamma release assay by age group in Japan","volume":"92","author":"Kato","year":"2017","journal-title":"Kekkaku"},{"issue":"4","key":"10.1016\/j.ero.2025.10.003_bib0014","first-page":"503","article-title":"Effectiveness of interferon-gamma release assays in the tuberculosis contact investigation of elderly people","volume":"89","author":"Seto","year":"2014","journal-title":"Kekkaku"},{"issue":"9","key":"10.1016\/j.ero.2025.10.003_bib0015","first-page":"1021","article-title":"Waning of the specific interferon-gamma response after years of tuberculosis infection","volume":"11","author":"Mori","year":"2007","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T21:13:01Z","timestamp":1766005981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S3050708125000916"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.10.003","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How should we manage patients with interferon-gamma release assay-positive results in rheumatology: assessing the risk and long-term prognosis of tuberculosis","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}